ProShare Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $850K | Sell |
|
|||||
|
2025
Q1 | $810K | Sell |
|
|||||
|
2024
Q4 | $790K | Buy |
|
|||||
|
2024
Q3 | $706K | Buy |
|
|||||
|
2024
Q2 | $391K | Sell |
|
|||||
|
2024
Q1 | $415K | Buy |
|
|||||
|
2023
Q4 | $301K | Buy |
|
|||||
|
2023
Q3 | $187K | Buy |
|
|||||
|
2023
Q2 | $297K | Buy |
|
|||||
|
2023
Q1 | $204K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $317K | Sell |
|
|||||
|
2021
Q4 | $564K | Buy |
|
|||||
|
2021
Q3 | $282K | Sell |
|
|||||
|
2021
Q2 | $836K | Buy |
|
|||||
|
2021
Q1 | $398K | Buy |
|
|||||
|
2020
Q4 | $260K | Buy |
|